P. Tilleul

发表

Impact of ASCO guidelines for the use of hematopoietic colony stimulating factors (CSFs): survey results of fifteen Paris university hospitals

J. Fontan, I. Debrix, I. Madelaine, 1999, Pharmacy World and Science.

Optimizing fluoroquinolone utilization in a public hospital: a prospective study of educational intervention

G. Offenstadt, P. Tilleul, K. Lacombe, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Desflurane improves the throughput of patients in the PACU. A cost-effectiveness comparison with isoflurane

M. Beaussier, A. Lienhart, P. Balladur, 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Cost of managing anemia in end-stage renal disease: the experience of five French dialysis centers

P. Tilleul, G. Deray, J. Rottembourg, 2015, The European Journal of Health Economics.

Cost Consequences of Adjuvant Capecitabine, Mayo Clinic and de Gramont Regimens for Stage III Colon Cancer in the French Setting

M. Ychou, J. Douillard, J. Seitz, 2008, Oncology.

Multicenter study of the impact of prescription guidelines on the use of colony stimulating factors

J. Fontan, I. Debrix, I. Madelaine, 2000, Anti-cancer drugs.

An observational evaluation of the rate of awakening after isoflurane or desflurane used in daily clinical practice.

M. Beaussier, P. Balladur, P. Tilleul, 2000, Journal of clinical anesthesia.

Identification of the major degradation pathways of ticagrelor.

P. Tilleul, M. Bernard, W. Akrout, 2015, Journal of pharmaceutical and biomedical analysis.

A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.

O. Lortholary, P. Tilleul, R. Herbrecht, 2004, The Journal of antimicrobial chemotherapy.

Introduction of biosimilar pegfilgrastim in France: Economic analysis of switching from originator

P. Tilleul, B. Rodgers-Gray, J. Edwards, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Antiproliferative activity of a liposomal delivery system of mitoxantrone on rabbit subconjunctival fibroblasts in an ex-vivo model.

W. Rostène, P. Denis, P. Tilleul, 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Investigating therapeutic usage of combined Ticagrelor and Aspirin through solid‐state and analytical studies

P. Tilleul, N. Yagoubi, B. Do, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Prophylactic low-molecular-weight heparin: prescription practice in an intensive care unit.

B. Guidet, E. Maury, G. Offenstadt, 2006, Journal of critical care.

Cost analysis applied to postoperative analgesia regimens: a comparison between parecoxib and propacetamol

M. Beaussier, P. Tilleul, A. Lienhart, 2007, Pharmacy World & Science.

Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination.

K. Hoang-Xuan, M. Sanson, P. Laurent-Puig, 2019, JCO precision oncology.

Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France

A. Le Monnier, P. Tilleul, A. Dinh, 2017, Journal of medical economics.

Cost-effectiveness analysis comparing epidural, patient-controlled intravenous morphine, and continuous wound infiltration for postoperative pain management after open abdominal surgery.

M. Beaussier, J. Hutton, P. Tilleul, 2012, British journal of anaesthesia.

Unmet needs in clinical nutrition in oncology: a multinational analysis of real-world evidence

P. Pedrazzoli, G. Zalcman, F. Goldwasser, 2020, Therapeutic advances in medical oncology.

Estimated Annual Costs of Prophylaxis and Treatment of Venous Thromboembolic Events Associated With Major Orthopedic Surgery in France

P. Tilleul, Y. Ozier, A. Lafuma, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation

P. Tilleul, S. Lesage, A. Najman, 1992, The Lancet.

Evaluation of the stability and efficacy of rhGM-CSF as a topical agent in a gel formulation.

P. Tilleul, P. Senet, B. Mons, 2002, Journal of wound care.

Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy

G. Hejblum, C. Chouaid, P. Tilleul, 2009, Current medical research and opinion.

[Experimental use of liposomes carrying an antimetabolite (mitoxantrone) in filtering surgery].

W. Rostène, P. Denis, M. Baudrimont, 1993, Journal francais d'ophtalmologie.

Assisted peritoneal dialysis—an evolving dialysis modality

P. Chevallier, P. Tilleul, G. Deray, 2007 .

Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments

P. Tilleul, A. Fekkar, A. Bellanger, 2018, European journal of hospital pharmacy : science and practice.

Plasma itraconazole concentrations in patients with neutropenia: advantages of a divided daily dosage regimen.

G. Cheymol, J. Poirier, P. Tilleul, 1997, Therapeutic drug monitoring.

Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs

P. Tilleul, S. Ramos, A. Bellanger, 2022, Pharmaceutics.

Intravenous drug preparation practices: a survey in a French university hospital

P. Tilleul, Claude Schmitt, C. Schmitt, 2003, Pharmacy World and Science.

The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.

B. Milleron, J. Fontan, I. Debrix, 2001, Clinical therapeutics.

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment

Z. Amoura, P. Tilleul, J. Haroche, 2019, Journal of Neurology.

Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors.

M. Delmée, M. Guiguet, P. Tilleul, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Rapid detection of Clostridium difficile toxin A in stool specimens.

P. Tilleul, F. Barbut, V. Lalande, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database

J. Gourmelen, W. Jacot, P. Tilleul, 2017, Journal of medical economics.

[Study impacto: Descriptive analyzis of pharmacist's clinical practice in onco-hematology].

F. Pinguet, D. Braguer, J. Vigneron, 2015, Annales Pharmaceutiques Françaises.

Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: a Markov analysis.

C. Chouaid, P. Tilleul, I. Borget, 2005, Lung cancer.

Effects of different formulations of mitoxantrone (solutions, nanospheres, liposomes) on glaucoma surgery in rabbits.

J. Nordmann, W. Rostène, P. Denis, 1997, Ophthalmic research.

A multicenter prospective observational study of the conformity of temozolomide prescriptions in France

F. Pinguet, S. Taillibert, O. Chinot, 2012, Pharmacoepidemiology and drug safety.

Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study.

R. Tubiana, C. Katlama, G. Peytavin, 2019, The Journal of antimicrobial chemotherapy.